Persad Emma, O'Loughlin Clare Aa, Kaur Simi, Wagner Gernot, Matyas Nina, Hassler-Di Fratta Melanie Rosalia, Nussbaumer-Streit Barbara
Cochrane Austria, Department for Evidence-based Medicine and Evaluation, Danube University Krems, Krems, Austria.
Karl Landsteiner University of Health Sciences, Krems, Austria.
Cochrane Database Syst Rev. 2021 Apr 23;4(4):CD000479. doi: 10.1002/14651858.CD000479.pub6.
Varicoceles are associated with male subfertility; however, the mechanisms by which varicoceles affect fertility have yet to be satisfactorily explained. Several treatment options exist, including surgical or radiological treatment, however the safest and most efficient treatment remains unclear. OBJECTIVES: To evaluate the effectiveness and safety of surgical and radiological treatment of varicoceles on live birth rate, adverse events, pregnancy rate, varicocele recurrence, and quality of life amongst couples where the adult male has a varicocele, and the female partner of childbearing age has no fertility problems.
We searched the following databases on 4 April 2020: the Cochrane Gynaecology and Fertility Group Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO, and CINAHL. We also searched the trial registries and reference lists of articles.
We included randomised controlled trials (RCTs) if they were relevant to the clinical question posed and compared different forms of surgical ligation, different forms of radiological treatments, surgical treatment compared to radiological treatment, or one of these aforementioned treatment forms compared to non-surgical methods, delayed treatment, or no treatment. We extracted data if the studies reported on live birth, adverse events, pregnancy, varicocele recurrence, and quality of life.
Screening of abstracts and full-text publications, alongside data extraction and 'Risk of bias' assessment, were done dually using the Covidence software. When we had sufficient data, we calculated random-effects (Mantel-Haenszel) meta-analyses; otherwise, we reported results narratively. We used the I statistic to analyse statistical heterogeneity. We planned to use funnel plots to assess publication bias in meta-analyses with at least 10 included studies. We dually rated the risk of bias of studies using the Cochrane 'Risk of bias' tool, and the certainty of evidence for each outcome using the GRADE approach.
We identified 1897 citations after de-duplicating the search results. We excluded 1773 during title and abstract screening. From the 113 new full texts assessed in addition to the 10 studies (11 references) included in the previous version of this review, we included 38 new studies, resulting in a total of 48 studies (59 references) in the review providing data for 5384 participants. Two studies (three references) are ongoing studies and two studies are awaiting classification. Treatment versus non-surgical, non-radiological, delayed, or no treatment Two studies comparing surgical or radiological treatment versus no treatment reported on live birth with differing directions of effect. As a result, we are uncertain whether surgical or radiological treatment improves live birth rates when compared to no treatment (risk ratio (RR) 2.27, 95% confidence interval (CI) 0.19 to 26.93; 2 RCTs, N = 204; I = 74%, very low-certainty evidence). Treatment may improve pregnancy rates compared to delayed or no treatment (RR 1.55, 95% CI 1.06 to 2.26; 13 RCTs, N = 1193; I = 65%, low-certainty evidence). This suggests that couples with no or delayed treatment have a 21% chance of pregnancy, whilst the pregnancy rate after surgical or radiological treatment is between 22% and 48%. We identified no evidence on adverse events, varicocele recurrence, or quality of life for this comparison. Surgical versus radiological treatment We are uncertain about the effect of surgical versus radiological treatment on live birth and on the following adverse events: hydrocele formation, pain, epididymitis, haematoma, and suture granuloma. We are uncertain about the effect of surgical versus radiological treatment on pregnancy rate (RR 1.13, 95% CI 0.75 to 1.70; 5 RCTs, N = 456, low-certainty evidence) and varicocele recurrence (RR 1.31, 95% CI 0.82 to 2.08; 3 RCTs, N = 380, low-certainty evidence). We identified no evidence on quality of life for this comparison. Surgery versus other surgical treatment We identified 19 studies comparing microscopic subinguinal surgical treatment to any other surgical treatment. Microscopic subinguinal surgical treatment probably improves pregnancy rates slightly compared to other surgical treatments (RR 1.18, 95% CI 1.02 to 1.36; 12 RCTs, N = 1473, moderate-certainty evidence). This suggests that couples with microscopic subinguinal surgical treatment have a 10% to 14% chance of pregnancy after treatment, whilst the pregnancy rate in couples after other surgical treatments is 10%. This procedure also probably reduces the risk of varicocele recurrence (RR 0.48, 95% CI 0.29, 0.79; 14 RCTs, N = 1565, moderate-certainty evidence). This suggests that 0.4% to 1.1% of men undergoing microscopic subinguinal surgical treatment experience recurrent varicocele, whilst 1.4% of men undergoing other surgical treatments do. Results for the following adverse events were inconclusive: hydrocele formation, haematoma, abdominal distension, testicular atrophy, wound infection, scrotal pain, and oedema. We identified no evidence on live birth or quality of life for this comparison. Nine studies compared open inguinal surgical treatment to retroperitoneal surgical treatment. Due to small sample sizes and methodological limitations, we identified neither treatment type as superior or inferior to the other regarding adverse events, pregnancy rates, or varicocele recurrence. We identified no evidence on live birth or quality of life for this comparison. Radiological versus other radiological treatment One study compared two types of radiological treatment (sclerotherapy versus embolisation) and reported 13% varicocele recurrence in both groups. Due to the broad confidence interval, no valid conclusion could be drawn (RR 1.00, 95% CI 0.16 to 6.20; 1 RCT, N = 30, very low-certainty evidence). We identified no evidence on live birth, adverse events, pregnancy, or quality of life for this comparison.
AUTHORS' CONCLUSIONS: Based on the limited evidence, it remains uncertain whether any treatment (surgical or radiological) compared to no treatment in subfertile men may be of benefit on live birth rates; however, treatment may improve the chances for pregnancy. The evidence was also insufficient to determine whether surgical treatment was superior to radiological treatment. However, microscopic subinguinal surgical treatment probably improves pregnancy rates and reduces the risk of varicocele recurrence compared to other surgical treatments. High-quality, head-to-head comparative RCTs focusing on live birth rate and also assessing adverse events and quality of life are warranted.
精索静脉曲张与男性生育力低下有关;然而,精索静脉曲张影响生育的机制尚未得到令人满意的解释。目前有多种治疗选择,包括手术或放射治疗,但最安全、最有效的治疗方法仍不明确。
评估精索静脉曲张手术和放射治疗对成年男性患有精索静脉曲张且育龄女性伴侣无生育问题的夫妇的活产率、不良事件、妊娠率、精索静脉曲张复发率和生活质量的有效性和安全性。
我们于2020年4月4日检索了以下数据库:Cochrane妇科和生育组专业注册库、Cochrane系统评价数据库、医学期刊数据库、荷兰医学文摘数据库、心理学文摘数据库和护理学与健康领域数据库。我们还检索了试验注册库和文章的参考文献列表。
如果随机对照试验(RCT)与所提出的临床问题相关,并比较了不同形式的手术结扎、不同形式的放射治疗、手术治疗与放射治疗,或上述治疗形式之一与非手术方法、延迟治疗或不治疗,则纳入研究。如果研究报告了活产、不良事件、妊娠、精索静脉曲张复发和生活质量,则提取数据。
使用Covidence软件对摘要和全文出版物进行双重筛选,同时进行数据提取和“偏倚风险”评估。当我们有足够的数据时,我们计算随机效应(Mantel-Haenszel)荟萃分析;否则,我们以叙述方式报告结果。我们使用I统计量分析统计异质性。我们计划使用漏斗图评估纳入至少10项研究的荟萃分析中的发表偏倚。我们使用Cochrane“偏倚风险”工具对研究的偏倚风险进行双重评分,并使用GRADE方法对每个结果的证据确定性进行评分。
在对检索结果进行去重后,我们共识别出1897条引用。在标题和摘要筛选过程中,我们排除了1773条。除了本综述上一版中纳入的10项研究(11篇参考文献)外,我们还评估了113篇新的全文,从中纳入了38项新研究,最终本综述共纳入48项研究(59篇参考文献),为5384名参与者提供了数据。两项研究(三篇参考文献)正在进行中,两项研究正在等待分类。
治疗与非手术、非放射、延迟或不治疗
两项比较手术或放射治疗与不治疗的研究报告了活产情况,但其效应方向不同。因此,与不治疗相比,我们不确定手术或放射治疗是否能提高活产率(风险比(RR)2.27,95%置信区间(CI)0.19至26.93;2项RCT,N = 204;I² = 74%,极低确定性证据)。与延迟治疗或不治疗相比,治疗可能会提高妊娠率(RR 1.55,95%CI 1.06至2.26;13项RCT,N = 1193;I² = 65%,低确定性证据)。这表明未治疗或延迟治疗的夫妇妊娠几率为21%,而手术或放射治疗后的妊娠率在22%至48%之间。对于此比较,我们未发现关于不良事件、精索静脉曲张复发或生活质量的证据。
手术与放射治疗
鞘膜积液形成、疼痛、附睾炎、血肿和缝线肉芽肿。我们不确定手术与放射治疗对妊娠率(RR 1.13,95%CI 0.75至1.70;5项RCT,N = 456,低确定性证据)和精索静脉曲张复发(RR 1.31,95%CI 0.82至2.08;3项RCT,N = 380,低确定性证据)的影响。对于此比较,我们未发现关于生活质量的证据。
手术与其他手术治疗
我们识别出19项比较显微镜下腹股沟下手术治疗与其他任何手术治疗的研究。与其他手术治疗相比,显微镜下腹股沟下手术治疗可能会略微提高妊娠率(RR 1.18,95%CI 1.02至1.36;12项RCT,N = 1473,中等确定性证据)。这表明接受显微镜下腹股沟下手术治疗的夫妇治疗后妊娠几率为10%至14%,而接受其他手术治疗的夫妇妊娠率为10%。该手术还可能降低精索静脉曲张复发的风险(RR 0.48,95%CI 0.29至0.79;14项RCT,N = 1565,中等确定性证据)。这表明接受显微镜下腹股沟下手术治疗的男性中有0.4%至1.1%会出现精索静脉曲张复发,而接受其他手术治疗的男性中有1.4%会出现复发。以下不良事件的结果尚无定论:鞘膜积液形成﹑血肿﹑腹胀﹑睾丸萎缩﹑伤口感染﹑阴囊疼痛和水肿。对于此比较,我们未发现关于活产或生活质量的证据。
9项研究比较了开放腹股沟手术治疗与腹膜后手术治疗。由于样本量小和方法学上的局限性,我们未确定哪种治疗方式在不良事件﹑妊娠率或精索静脉曲张复发方面更优或更劣。对于此比较,我们未发现关于活产或生活质量的证据。
放射治疗与其他放射治疗
一项研究比较了两种放射治疗(硬化疗法与栓塞术),两组的精索静脉曲张复发率均为13%。由于置信区间较宽,无法得出有效结论(RR 1.00,95%CI 0.16至6.20;1项RCT,N = 30,极低确定性证据)。对于此比较,我们未发现关于活产、不良事件、妊娠或生活质量的证据。
基于有限的证据,与不育男性不治疗相比,任何治疗(手术或放射治疗)是否能提高活产率仍不确定;然而,治疗可能会增加妊娠几率。证据也不足以确定手术治疗是否优于放射治疗。然而,与其他手术治疗相比,显微镜下腹股沟下手术治疗可能会提高妊娠率并降低精索静脉曲张复发的风险。有必要开展高质量的、直接比较的RCT,重点关注活产率,并评估不良事件和生活质量。